Gene · 54567
Papers4,267
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 4,267
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Application of ADSCs and their Exosomes in Scar Prevention. | Stem Cell Rev Rep | 2022 | 34510359 | PubTator, text mining | PubMed |
| Delta-like ligand 4 level in colorectal cancer is associated with tumor aggressiveness and clinical outcome. | Cancer Biomark | 2022 | 34487019 | PubTator, text mining | PubMed |
| Delta-like 1-Expressing Cells at the Gland Base Promote Proliferation of Gastric Antral Stem Cells in Mouse. | Cell Mol Gastroenterol Hepatol | 2022 | 34438113 | PubTator, text mining | PubMed |
| Adult stem cell niches for tissue homeostasis. | J Cell Physiol | 2022 | 34435361 | PubTator, text mining | PubMed |
| The mini player with diverse functions: extracellular vesicles in cell biology, disease, and therapeutics. | Protein Cell | 2022 | 34374936 | PubTator, text mining | PubMed |
| Ionic Channels as Potential Targets for the Treatment of Autism Spectrum Disorder: A Review. | Curr Neuropharmacol | 2022 | 34370640 | PubTator, text mining | PubMed |
| Generation of functional human thymic cells from induced pluripotent stem cells. | J Allergy Clin Immunol | 2022 | 34331993 | PubTator, text mining | PubMed |
| Spelling Out CICs: A Multi-Organ Examination of the Contributions of Cancer Initiating Cells' Role in Tumor Progression. | Stem Cell Rev Rep | 2022 | 34244971 | PubTator, text mining | PubMed |
| COVID-19 Morbidity and Severity in Patients With Age-Related Macular Degeneration: A Korean Nationwide Cohort Study. | Am J Ophthalmol | 2022 | 34102151 | PubTator, text mining | PubMed |
| Two-Dimensional and Three-Dimensional Cartilage Model Platforms for Drug Evaluation and High-Throughput Screening Assays. | Tissue Eng Part B Rev | 2022 | 34010074 | PubTator, text mining | PubMed |
| Contradictory Effect of Notch1 and Notch2 on Phosphatase and Tensin Homolog and its Influence on Glioblastoma Angiogenesis. | Galen Med J | 2021 | 36643842 | PubTator, text mining | PubMed |
| Genetic and epigenetic mechanisms in the development of congenital heart diseases. | World J Pediatr Surg | 2021 | 36474778 | PubTator, text mining | PubMed |
| Notch signaling in female cancers: a multifaceted node to overcome drug resistance. | Cancer Drug Resist | 2021 | 35582386 | PubTator, text mining | PubMed |
| Anti-angiogenic therapy in ovarian cancer: current situation & prospects. | Indian J Med Res | 2021 | 35532586 | PubTator, text mining | PubMed |
| Exosomes Immunity Strategy: A Novel Approach for Ameliorating Intervertebral Disc Degeneration. | Front Cell Dev Biol | 2021 | 35223870 | PubTator, text mining | PubMed |
| MIR100HG Regulates CALD1 Gene Expression by Targeting miR-142-5p to Affect the Progression of Bladder Cancer Cells in vitro, as Revealed by Transcriptome Sequencing. | Front Mol Biosci | 2021 | 35127818 | PubTator, text mining | PubMed |
| The Notch1 gene may control cell chemoresistance in esophageal squamous cell cancer. | Transl Cancer Res | 2021 | 35116634 | PubTator, text mining | PubMed |
| High expression of Dll4 and CD44V6 is associated with clinicopathological characteristics and poor prognosis in osteosarcoma patients. | Transl Cancer Res | 2021 | 35116433 | PubTator, text mining | PubMed |
| Mechanism of Action of Mesenchymal Stem Cell-Derived Exosomes in the Intervertebral Disc Degeneration Treatment and Bone Repair and Regeneration. | Front Cell Dev Biol | 2021 | 35096846 | PubTator, text mining | PubMed |
| A review of neovascular glaucoma. Etiopathogenesis and treatment. | Rom J Ophthalmol | 2021 | 35087972 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54567/papers?page=61